|
´ë¶È¤Î¼Â̳¤ËÂ礤¯±Æ¶Á¤¹¤ëInequitable Conduct¤Ë´Ø¤¹¤ëTherasense v. BeconÂçË¡ÄîȽ·è¤¬½Ð¤Þ¤·¤¿¤Î¤Ç¤ªÃΤ餻¤¤¤¿¤·¤Þ¤¹¡£ |
ÆÃµö
[ ¥ê¥¹¥È | ¾ÜºÙ ]
|
2011ǯ5·î25Æü¤ËTHERASENSE, INC. v. BECTON, DICKINSON AND COMPANYÂçË¡ÄîȽ·è¤¬¤Ç¤Þ¤·¤¿¡£ |
|
2011ǯ4·î15Æü¡¢Ï¢Ë®½ä²ó¹µÁʺÛȽ½ê¤Ï¡¢In re TanakaȽ·è¤Ë¤ª¤¤¤Æ¡¢Reissue Patent Application¤Ë¤è¤ê¡¢¥ª¥ê¥¸¥Ê¥ë¥¯¥ì¡¼¥à¤ò»Ä¤·¤¿¤Þ¤Þ¡¢½¾Â°¥¯¥ì¡¼¥à¤òÄɲ乤뤳¤È¤òǧ¤á¤Þ¤·¤¿¡£ |
|
ÊÆ¹ñÆÃµöÄ£¤Ï¡¢2011ǯ5·î4Æü¤«¤é¿·¤¿¤ÊÍ¥À迳ºº¡ÊPrioritized Examination¡Ë¤ò¼Â»Ü¤·¤Þ¤¹¡Ê2011ǯ4·î4Æü¤ÎFederal Register»²¾È¡Ë¡£ |
|
ÊÆ¹ñÆÃµöÄ£¤¬¡¢º£²ó¤ÎÅìËÌ´ØÅìÂç¿ÌºÒ¤ÎÈïºÒÃϤνдê¿Í¤ËÂФ·¡¢ÆÃÊÌÁ¼ÃÖ¤ò¤È¤ë¤Èȯɽ¤¤¤¿¤·¤Þ¤·¤¿¡£ |




